Pharmaceuticals

$3.31 Billion Forecast for Pentavalent Market by 2029, Backed by Demand and Innovation

May 27, 2025 by The Business Research Company

Discover trends, market shifts, and competitive outlooks for the pentavalent industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Projected Market Size and Growth Rates for the Pentavalent Market From 2025 To 2029?#_x000D_

The market size for pentavalent has shown a consistent incline in the previous years. There is an expectation for it to rise from $2.62 billion in 2024 to around $2.73 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historic period include widespread immunization drives, government-run vaccination schemes, prevention efforts against various ailments, heightened public health consciousness, and international collaborations and funding._x000D_

_x000D_

In the foreseeable future, the pentavalent market size is projected to experience continuous growth. It is set to inflate to a value of $3.31 billion by 2029, maintaining a Compound Annual Growth Rate (CAGR) of 5.0%. The surge during the projected timeline can be linked to ongoing worldwide immunization drives, the broadening scope of vaccination programs, introduction to new locations, research and development activities, along with partnerships aiming at vaccine accessibility. Notable trends during the forecast period encompass global health movements and financial backing, campaigns for public consciousness and education, government legislations and regulatory structures, and advancements in vaccine production technology._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp_x000D_

_x000D_

#What Are the Core Growth Drivers Propelling the Pentavalent Market Forward?#_x000D_

The growth of the pentavalent market is anticipated to be expedited by the surging incidence of diphtheria. Diphtheria, an exceptionally contagious and severe disease, is caused by Corynebacterium diphtheriae bacteria. It can result in serious trouble with eating and breathing, as well as potential skin ulcers. The pentavalent vaccine keeps children safe from diphtheria through three doses of a pentavalent immunization schedule. Consequently, the growing prevalence of diphtheria has been inflating the demand for pentavalent vaccines. For instance, in 2022, the World Health Organization, a Swiss agency of the United Nations, reported an unusually high count of diphtheria cases primarily in June and August 2022 through the International Health Regulations (IHR) reporting process. Out of the 144 documented cases from seven countries, a large number were among asylum seekers. Of the 144 patients, 97 (69%) were diagnosed clinically compatible, 44 (31%) were confirmed by laboratory to be toxigenic diphtheria, and 3 (2%) were suspected cases. Hence, the rising incidence of diphtheria is propelling the pentavalent market growth._x000D_

_x000D_

#What Segment Types Define the Pentavalent Market Structure?#_x000D_

The pentavalent market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate_x000D_

2) By Formulation Type: Lyophilized, Liquid_x000D_

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Sodium Stibogluconate: Injectable Form, Oral Form, Other Formulations_x000D_

2) By Meglumine Antimoniate: Injectable Form, Oral Form, Other Formulations_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9104&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Pentavalent Market?#_x000D_

Asia-Pacific was the largest region in the pentavalent market in 2024. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Emerging Trends that Are Influencing thePentavalent Industry Evolution?#_x000D_

In the pentavalent market, product innovation is rising as a prominent trend. A significant strategy of leading companies in the pentavalent market is the creation of inventive products to fortify their market presence. For example, Pfizer, an American pharmaceutical firm active in the pentavalent vaccines market, received approval for its Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents from The United States Food and Drug Administration, a US federal agency within the Department of Health and Human Services, in December 2022. The vaccine is designed to prevent meningococcal disease in individuals aged between 10 and 25. A distinctive feature of the MenABCWY vaccine is its dual-component combination, offering protection against the majority of invasive meningococcal diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report_x000D_

_x000D_

#What Is the Definition of the Pentavalent Market?#_x000D_

Pentavalent refers to a vaccine that protects a child from life-threatening diseases. This vaccine is used to protect infants and young children from rotavirus infection. Rotavirus infection can result in fever, vomiting, and diarrhea._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9104_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_